Consent for Amendments, Participation in Investor Conferences, and Stock Price Updates - Research Report on Perrigo, Waters, HealthSouth, Insulet and Globus
NEW YORK, November 26, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Analysts' Corner announced new research reports highlighting Perrigo Company (NYSE:PRGO),
Waters Corporation (NYSE:WAT), HealthSouth Corp (NYSE:HLS), Insulet Corporation (NASDAQ:PODD) and Globus Medical Inc (NYSE:GMED). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Perrigo Company Research Report
On November 21, 2013, Perrigo Company (Perrigo) announced that it has received the requisite consents to amend the indenture governing its previously announced tender offer and consent solicitation for its 2.950% Notes due 2023. Perrigo stated that the Consent Solicitation expired at 5:00 p.m. New York City time on November 19, 2013, and at the consent deadline, 95.27% of the outstanding Notes had been validly tendered and not withdrawn. As a result, the requisite number of consents has been received with respect to the Consent Solicitation. Accordingly, the Company and Wells Fargo Bank, National Association, the trustee under the indenture governing the Notes, entered into a supplemental indenture, which would amend the indenture under which the Notes were issued. The Full Research Report on Perrigo Company - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/4168_PRGO
Waters Corporation Research Report
On November 21, 2013, Waters Corporation's (Waters) stock rose 0.98% to end the day's trading session at $101.38. Shares of Waters have increased 0.13% over the previous three trading sessions, while the Dow Jones Industrial Average Index rose 0.21% during the same period. The Full Research Report on Waters Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/2fff_WAT
HealthSouth Corp Research Report
On November 21, 2013, shares of HealthSouth Corp (HealthSouth) rose 0.15% to end trading session at $34.31. Over the previous three trading sessions, HealthSouth's shares dipped 0.78%, compared to the Dow Jones Industrial Average Index, which rose 0.21% during the same period. The Full Research Report on HealthSouth Corp - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/9080_HLS
Insulet Corporation Research Report
On November 21, 2013, Insulet Corporation (Insulet) announced that it will participate in two investor conferences in December 2013. According to the Company, its management is scheduled to make a presentation at the Piper Jaffray 25th Annual Healthcare Conference, to be held at New York Palace Hotel in New York City, on December 3, 2013 at 3:30 p.m. ET. Additionally, the Company will also take part in the Oppenheimer 24th Annual Healthcare Conference, to be held at Crowne Plaza Hotel in New York City, on December 10, 2013 at 10:55 a.m. ET. Insulet informed that material information and audio webcasts for these presentations will be available at the investor's section of Insulet's website, wherein a replay of each webcast will also be available for 10 days after the initial presentation. The Full Research Report on Insulet Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/75e4_PODD
Globus Medical Inc Research Report
On November 21, 2013, Globus Medical Inc's (Globus) shares closed at $18.54, indicating a rise of 0.98%. Over the previous three trading sessions, shares of Globus increased 1.09%, while the Dow Jones Industrial Average Index increased 0.21% during the same period. The Full Research Report on Globus Medical Inc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/5898_GMED
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to making mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
http://www.analystscorner.com/
SOURCE Analysts' Corner
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article